True North Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$438K Sell
6,850
-60
-0.9% -$3.94K 0.04% 191
2026
Q1
$492K Sell
6,910
-59
-0.8% -$4.65K 0.06% 167
2025
Q4
$572K Sell
6,969
-18
-0.3% -$1.4K 0.07% 149
2025
Q3
$525K Buy
6,987
+139
+2% +$10.4K 0.08% 127
2025
Q2
$507K Buy
6,848
+24
+0.4% +$1.67K 0.1% 130
2025
Q1
$551K Buy
6,824
+51
+0.8% +$4.38K 0.1% 128
2024
Q4
$530K Sell
6,773
-84
-1% -$7.14K 0.12% 95
2024
Q3
$644K Buy
+6,857
New +$576K 0.17% 86
2024
Q2
Sell
-2,988
Closed -$272K 203
2024
Q1
$272K Sell
2,988
-3
-0.1% -$250 0.08% 150
2023
Q4
$231K Sell
2,991
-2,079
-41% -$146K 0.06% 168
2023
Q3
$345K Sell
5,070
-639
-11% -$46.5K 0.11% 130
2023
Q2
$464K Hold
5,709
0.13% 125
2023
Q1
$468K Buy
+5,709
New +$408K 0.14% 128

Other funds holding GEHC

True North Advisors's GEHC Position: Q2 2026 in Review

True North Advisors reduced its GE HealthCare (GEHC) stake by 0.87% in Q2 2026, selling an estimated $3.94K and leaving 6,850 shares worth $438K. The position accounts for 0.04% of the portfolio, ranked #191.

True North Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $644K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • True North Advisors held 6,850 shares of GE HealthCare worth $438K as of Q2 2026.
  • True North Advisors sold 60 GE HealthCare shares in Q2 2026, an estimated $3.94K.
  • GE HealthCare made up 0.04% of True North Advisors's portfolio in Q2 2026, its #191 holding.
  • True North Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • True North Advisors's GE HealthCare position peaked at $644K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.